• Explore /
  • Poster
  • / Randomized phase II studies comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab or cetuximab with FOLFOX or FOLFIRI.

Randomized phase II studies comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab or cetuximab with FOLFOX or FOLFIRI.

Abstract Poster

Authors

null

Marc Van Den Eynde

Université Catholique de Louvain, Brussels, Belgium

Marc Van Den Eynde , Marie-Laure Castella , Jean-Pascal H. Machiels , Yves Humblet , Jean-Luc Re Canon , Ghislain Houbiers , Gauthier Demolin , Lionel A. D'Hondt , Jean-Charles Coche , Daniel Van Daele , Thierry Delaunoit , Jean Charles. Goeminne , Gabriella Beniuga , Geraldine Pairet , Christine Sempoux , Anne Jouret-Mourin , Aline Van Maanen , Javier Carrasco

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01858649 (BEVONCO) NCT01858662 (CETONCO)

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr TPS795)

DOI

10.1200/jco.2015.33.3_suppl.tps795

Abstract #

TPS795

Poster Bd #

F33

Abstract Disclosures

Similar Posters

First Author: Scott Kopetz

First Author: Stefan Kasper

First Author: Stefano Cascinu

First Author: Federico Innocenti